| BioCyc:HUMAN_PWY-4061 |
glutathione-mediated detoxification I |
| BioCyc:HUMAN_PWY66-375 |
leukotriene biosynthesis |
| BioCyc:HUMAN_PWY-4041 |
γ-glutamyl cycle |
| BioCyc:META_PWY-4041 |
γ-glutamyl cycle |
| BioCyc:META_PWY-4061 |
glutathione-mediated detoxification I |
| BioCyc:MOUSE_PWY-4041 |
γ-glutamyl cycle |
| BioCyc:META_PWY66-375 |
leukotriene biosynthesis |
| Reactome:R-MMU-9753281 |
APAP ADME |
| Reactome:R-RNO-9748784 |
Drug ADME |
| Reactome:R-RNO-9753281 |
APAP ADME |
| Reactome:R-HSA-9658195 |
Leishmania infection |
| Reactome:R-HSA-9664433 |
Leishmania parasite growth and survival |
| Reactome:R-HSA-9753281 |
APAP ADME |
| Reactome:R-MMU-9748784 |
Drug ADME |
| Reactome:R-HSA-9662851 |
Anti-inflammatory response favouring Leishmania parasite infection |
| Reactome:R-HSA-9664535 |
LTC4-CYSLTR mediated IL4 production |
| Reactome:R-HSA-9748784 |
Drug ADME |
| Reactome:R-HSA-9824443 |
Parasitic Infection Pathways |
| Reactome:R-HSA-2142691 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-HSA-211859 |
Biological oxidations |
| Reactome:R-HSA-5423646 |
Aflatoxin activation and detoxification |
| Reactome:R-HSA-1643685 |
Disease |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-556833 |
Metabolism of lipids |
| Reactome:R-MMU-2142691 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-MMU-211859 |
Biological oxidations |
| Reactome:R-MMU-5423646 |
Aflatoxin activation and detoxification |
| Reactome:R-RNO-8978868 |
Fatty acid metabolism |
| Reactome:R-RNO-156590 |
Glutathione conjugation |
| Reactome:R-HSA-556833 |
Metabolism of lipids |
| Reactome:R-HSA-8978868 |
Fatty acid metabolism |
| Reactome:R-HSA-156580 |
Phase II - Conjugation of compounds |
| Reactome:R-MMU-8978868 |
Fatty acid metabolism |
| Reactome:R-MMU-156580 |
Phase II - Conjugation of compounds |
| Reactome:R-RNO-2142753 |
Arachidonate metabolism |
| Reactome:R-RNO-211859 |
Biological oxidations |
| Reactome:R-RNO-5423646 |
Aflatoxin activation and detoxification |
| Reactome:R-HSA-156590 |
Glutathione conjugation |
| Reactome:R-MMU-156590 |
Glutathione conjugation |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-556833 |
Metabolism of lipids |
| Reactome:R-RNO-2142691 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| Reactome:R-RNO-174403 |
Glutathione synthesis and recycling |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-2142753 |
Arachidonate metabolism |
| Reactome:R-HSA-174403 |
Glutathione synthesis and recycling |
| Reactome:R-HSA-5663205 |
Infectious disease |
| Reactome:R-MMU-2142753 |
Arachidonate metabolism |
| Reactome:R-MMU-174403 |
Glutathione synthesis and recycling |
| Reactome:R-RNO-156580 |
Phase II - Conjugation of compounds |
| WikiPathways:WP4518 |
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
| PathBank:SMP0000083 |
Acetylsalicylic Acid Action Pathway |
| PathBank:SMP0000087 |
Rofecoxib Action Pathway |
| PathBank:SMP0000094 |
Sulindac Action Pathway |
| PathBank:SMP0000104 |
Indomethacin Action Pathway |
| PathBank:SMP0000120 |
Naproxen Action Pathway |
| PathBank:SMP0000106 |
Meloxicam Action Pathway |
| PathBank:SMP0000693 |
Antrafenine Action Pathway |
| PathBank:SMP0000697 |
Flurbiprofen Action Pathway |
| PathBank:SMP0000701 |
Phenylbutazone Action Pathway |
| PathBank:SMP0000705 |
Tiaprofenic Acid Action Pathway |
| PathBank:SMP0000709 |
Salicylic Acid Action Pathway |
| PathBank:SMP0000075 |
Arachidonic Acid Metabolism |
| PathBank:SMP0000086 |
Ibuprofen Action Pathway |
| PathBank:SMP0000093 |
Diclofenac Action Pathway |
| PathBank:SMP0000098 |
Ketorolac Action Pathway |
| PathBank:SMP0000102 |
Bromfenac Action Pathway |
| PathBank:SMP0000114 |
Nabumetone Action Pathway |
| PathBank:SMP0000692 |
Antipyrine Action Pathway |
| PathBank:SMP0000696 |
Fenoprofen Action Pathway |
| PathBank:SMP0000700 |
Lornoxicam Action Pathway |
| PathBank:SMP0000704 |
Tolmetin Action Pathway |
| PathBank:SMP0000708 |
Salicylate-Sodium Action Pathway |
| PathBank:SMP0000077 |
Piroxicam Action Pathway |
| PathBank:SMP0000084 |
Etodolac Action Pathway |
| PathBank:SMP0000109 |
Mefenamic Acid Action Pathway |
| PathBank:SMP0000289 |
Diflunisal Action Pathway |
| PathBank:SMP0000116 |
Valdecoxib Action Pathway |
| PathBank:SMP0000694 |
Carprofen Action Pathway |
| PathBank:SMP0000698 |
Magnesium Salicylate Action Pathway |
| PathBank:SMP0000702 |
Nepafenac Action Pathway |
| PathBank:SMP0000706 |
Tenoxicam Action Pathway |
| PathBank:SMP0000710 |
Acetaminophen Action Pathway |
| PathBank:SMP0000029 |
Selenoamino Acid Metabolism |
| PathBank:SMP0000353 |
Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000085 |
Ketoprofen Action Pathway |
| PathBank:SMP0000096 |
Celecoxib Action Pathway |
| PathBank:SMP0000101 |
Suprofen Action Pathway |
| PathBank:SMP0000113 |
Oxaprozin Action Pathway |
| PathBank:SMP0000695 |
Etoricoxib Action Pathway |
| PathBank:SMP0000699 |
Lumiracoxib Action Pathway |
| PathBank:SMP0000703 |
Trisalicylate-Choline Action Pathway |
| PathBank:SMP0000707 |
Salsalate Action Pathway |